We are asking the FDA to lead efforts to safeguard our American supply chain and to work with other federal and state agencies to stop bad actors from producing counterfeit drugs. Related Coverage: He said that the sky-high demand for GLP-1 drugs alongside high price tags and tight supplies is creating opportunities for bad actors to take advantage of consumers
If you want specific sources to read, check the New England Journal of Medicine trial on GLP1 agents for metabolic outcomes, the 2024 JAMA Internal Medicine paper on semaglutide and mental health, the 2024 Scientific Reports analysis, and recent reviews by regulatory agencies and psychiatry meetings that discuss case reports and signal detection
Leading Through Innovation: How Higher Education Benefits Teams are Managing GLP-1s As many colleges and universities grapple with tighter budgets, declining enrollments, and rising operational costs, the importance of strategic workforce engagement has never been more apparent
In the years since, she's been extremely open about her struggles with psoriasis and psoriatic arthritis, posting selfies during flare-ups and even penning an op-ed for her sister Kourtney Kardashian's POOSH wellness website on the subject
Utilizing the cutting-edge SubMagna SL HMW base, Keystone Pharmacy offers a solution that goes beyond conventional treatment methods